Lupin

US FDA grants EIR to Lupin’s Ankleshwar manufacturing facility

Read more

US FDA approves Lupin’s Mirabegron extended-release tablets

Read more

Health Canada approves Lupin’s Rymti

Read more

Lupin and DKSH sign exclusive licensing and supply agreement to market five biosimilar candidates in Philippines

Read more

Zydus Lifesciences and Lupin recall products in US

Read more

Lupin receives tentative US FDA approval for Dasatinib tablets

Read more

Lupin receives US FDA approval for Rufinamide tablets 

Read more

Lupin receives approval from US FDA for Meclizine Hydrochloride Tablets USP

Read more

Lupin gets approval from US FDA for Azilsartan Medoxomil Tablets

Read more

Accenture accelerates data-driven decision making for Lupin

Read more